Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

SHR

Schering Aktiengesel (SHR)

Bank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:SHR
FechaHoraFuenteTítuloSímboloCompañía
19/01/200702:20PR Newswire (US)Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative DiseasesNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
05/12/200607:25PR Newswire (US)Bayer Determines EUR 98.98 as Cash Compensation per Schering ShareNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
28/11/200602:45PR Newswire (US)Schering AG and Stanford University to Cooperate in the Field of Molecular ImagingNYSE:SHR
27/11/200601:33PR Newswire (US)Schering AG Maintains Strong Growth Momentum During First Nine Months of 2006NYSE:SHR
24/11/200611:25PR Newswire (US)NYSE Suspends Trading in Schering ADRsNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
23/11/200603:40PR Newswire (US)Betaferon(R) Approved in Australia for Earliest Stages of Multiple SclerosisNYSE:SHR
08/11/200600:54PR Newswire (US)Go-Ahead for Schering's Integration Into the Bayer GroupNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
31/10/200607:00PR Newswire (US)Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's LymphomaNYSE:SHR
30/10/200613:10PR Newswire (US)Entry in the Commercial Register - Agreement Between Bayer and Schering in Force - Resolution of Schering Extraordinary StockholNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
23/10/200609:39PR Newswire (US)FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple SclerosisNYSE:SHR
17/10/200608:47PR Newswire (US)Family Planning Programs in the Fight Against PovertyNYSE:SHR
05/10/200607:30PR Newswire (US)FDA Approves New Indication for YAZ(R) to Treat Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder (PMDD)NYSE:SHR
19/09/200602:58PR Newswire (US)Schering AG and Organon to Continue Research in Male Fertility Control SeparatelyNYSE:SHR
18/09/200609:01PR Newswire (US)Schering AG Licenses SEGRA Compound for Ophthalmic Use to Bausch & LombNYSE:SHR
15/09/200603:32PR Newswire (US)Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer DrugNYSE:SHR
14/09/200609:00PR Newswire (US)MEDRAD Employees Care in a Big Way: Facilities Suspend Operations Today so That 800 Can Volunteer in CommunityNYSE:SHR
14/09/200607:48PR Newswire (US)Stockholders Pave the Way for Bayer Schering PharmaNYSE:SHR
13/09/200605:32PR Newswire (US)Extraordinary Stockholders' Meeting of Schering AG in BerlinNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
04/09/200606:19PR Newswire (US)Schering AG Completes Reconstruction Projects in Indonesia and ThailandNYSE:SHR
01/09/200609:00PR Newswire (US)MEDRAD Holds Job Fair To Support Company GrowthNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
30/08/200605:13PR Newswire (US)Group Environmental Report for 2006 PublishedNYSE:SHR
16/08/200610:50PR Newswire (US)Frost & Sullivan Lauds MEDRAD Excellent Product Innovation Abilities in the MRI Coils MarketNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
04/08/200603:15PR Newswire (US)Extraordinary Stockholders' Meeting of Schering AG on September 13, 2006: Schering's Stockholders to Resolve on Domination andNYSE:SHR
02/08/200609:00PR Newswire (US)New MEDRAD 3.0T Prostate eCoil(TM) Enables Personalized Treatment PlanningNYSE:SHR
31/07/200609:49PR Newswire (US)Berlex Voluntarily Recalls Ultravist(R) Injection 370 mgI/mLNYSE:SHR
31/07/200609:36PR Newswire (US)Schering AG, Germany Announces Results of Two Clinical Trials With Sargramostim in Crohn's Disease PatientsNYSE:SHR
31/07/200609:21PR Newswire (US)Schering Voluntarily Recalls Ultravist(R) Injection 370 mgI/mlNYSE:SHR
31/07/200609:20PR Newswire (US)Bayer Offer Remains Unchanged Despite Voluntary Ultravist(R) Injection 370 mgI/ml Recall and Insufficient Results of Clinical PNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
26/07/200613:46PR Newswire (US)KPMG Values Schering AG Share at EUR 87.63NYSE:SHR
25/07/200602:28PR Newswire (US)Schering AG Raises Outlook After Strong First Half YearNYSE:SHR
 Showing the most relevant articles for your search:NYSE:SHR